Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Sexual dimorphism in the mouse bone marrow niche regulates hematopoietic engraftment via sex-specific Kdm5c/Cxcl12 signaling
Xiaojing Cui, … , Hui Zhong, Ying Liang
Xiaojing Cui, … , Hui Zhong, Ying Liang
Published January 21, 2025
Citation Information: J Clin Invest. 2025;135(5):e182125. https://doi.org/10.1172/JCI182125.
View: Text | PDF
Research Article

Sexual dimorphism in the mouse bone marrow niche regulates hematopoietic engraftment via sex-specific Kdm5c/Cxcl12 signaling

  • Text
  • PDF
Abstract

The bone marrow (BM) niche is critical in regulating hematopoiesis, and sexual dimorphism and its underlying mechanism in the BM niche and its impact on hematopoiesis are not well understood. We show that male mice exhibited a higher abundance of leptin-receptor–expressing mesenchymal stromal cells (LepR-MSCs) compared with female mice. Sex-mismatched coculture and BM transplantation showed that the male BM niche provided superior support for in vitro colony formation and in vivo hematopoietic engraftment. The cotransplantation of male stromal cells significantly enhanced engraftment in female recipients. Single-cell RNA-seq revealed that the lower expression of the X-linked lysine H3K4 demethylase, Kdm5c, in male MSCs led to the increased expression of Cxcl12. In MSC-specific Kdm5c-KO mouse model, the reduction of KDM5C in female MSCs enhanced MSC quantity and function, ultimately improving engraftment to the male level. Kdm5c thus plays a role in driving sexual dimorphism in the BM niche and hematopoietic regeneration. Our study unveils a sex-dependent mechanism governing the BM niche regulation and its impact on hematopoietic engraftment. The finding offers potential implications for enhancing BM transplantation efficacy in clinical settings by harnessing the resource of male MSCs or targeting Kdm5c.

Authors

Xiaojing Cui, Liming Hou, Bowen Yan, Jinpeng Liu, Cuiping Zhang, Pinpin Sui, Sheng Tong, Larry Luchsinger, Avital Mendelson, Daohong Zhou, Feng-chun Yang, Hui Zhong, Ying Liang

×

Figure 5

The sex chromosome gene Kdm5c contributes to the sex-specific differential expression of Cxcl12 in the BM niche.

Options: View larger image (or click on image) Download as PowerPoint
The sex chromosome gene Kdm5c contributes to the sex-specific differenti...
(A) H3K4me3 binding to the CpG enrichment region of Cxcl12 from the ChIP-seq data of UCSC and Cistrome Database. (B) The mRNA and protein level of KDM5C in male and female MSC cells. (C) ChIP-qPCR on male and female MSC cells for Cxcl12 promoter region using the antibody against KDM5C. (D) ChIP-qPCR on male and female MSC cells for Cxcl12 promoter region using the antibody against H3K4me3. (E) The mRNA level of Kdm5c in female MSC cells with control or shKdm5c transduction. (F) The protein level of KDM5C in female MSC cells with control or shKdm5c transduction. (G) ChIP-qPCR on female MSC cells treated with control or shKdm5c for Cxcl12 promoter region using the antibody against H3K4me3. (H) Cxcl12 mRNA level in control or shKdm5c transduced female MSC detected by real-time PCR. (I) The protein level of CXCL12 in female MSC cells with control or shKdm5c transduction detected by ELISA. The data were derived from 2 independent experiments with 2–3 replicates from each experiment, and were shown as mean ± SD, and analyzed by 2-tailed t test. (J) The mRNA level of Kdm5c in both male and female MSC with control or overexpressing (OE) Kdm5c plasmid. (K) The concentration of CXCL12 in male and female MSC culture supernatant overexpressed (OE) with or without Kdm5c was detected by ELISA. The data were derived from 2 independent experiments with 2–3 replicates from each experiment, were shown as mean ± SD, and were analyzed by 2 way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts